Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124125235 | 12412523 | 5 | F | 2016 | 20160627 | 20160527 | 20160726 | EXP | JP-UCBSA-2016019448 | UCB | 73.00 | YR | F | Y | 0.00000 | 20160726 | PH | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124125235 | 12412523 | 1 | PS | E Keppra | LEVETIRACETAM | 1 | Oral | 1000 MG, ONCE DAILY (QD) | 21035 | 1000 | MG | FILM-COATED TABLET | QD | ||||||
| 124125235 | 12412523 | 2 | SS | DEPAKENE | VALPROIC ACID | 1 | Oral | 800 MG DAILY | Y | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124125235 | 12412523 | 1 | Epilepsy |
| 124125235 | 12412523 | 2 | Product used for unknown indication |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124125235 | 12412523 | Platelet count decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124125235 | 12412523 | 1 | 20160229 | 0 | ||
| 124125235 | 12412523 | 2 | 20160229 | 2016 | 0 |